Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Therapeutics Acquisition Corp Cl A (RACA)

Therapeutics Acquisition Corp Cl A (RACA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
POINT Biopharma Debuts as Publicly Traded Next-Generation Radiotherapeutics Company Globe NewsWire - Wed Jun 30, 2021

Common stock to commence trading on the Nasdaq Capital Market on July 1, 2021 under the ticker symbol “PNT”

RACA : 10.27 (+2.19%)
Research Alliance Corp. I Announces Effectiveness of Registration Statement for Proposed Business Combination with POINT Business Wire - Wed Jun 9, 2021

Therapeutics Acquisition Corp, d/b/a Research Alliance Corp. I, a Delaware corporation (“the Company”) (Nasdaq: RACA) announced today that its registration statement on Form S-4 (File Number 333-254600)...

RACA : 10.27 (+2.19%)
POINT Biopharma Announces First Patients Dosed in Phase 3 Study of PNT2002 for mCRPC Business Wire - Fri Jun 4, 2021

POINT Biopharma Inc. (POINT), a global radiopharmaceutical company dedicated to successfully delivering precision radioligand therapy to cancer patients, today announced that it has successfully dosed...

RACA : 10.27 (+2.19%)
POINT Biopharma Announces First Patients Dosed in Phase 3 Study of PNT2002 for mCRPC Globe NewsWire - Fri Jun 4, 2021

INDIANAPOLIS, June 04, 2021 (GLOBE NEWSWIRE) -- POINT Biopharma Inc. (POINT), a global radiopharmaceutical company dedicated to successfully delivering precision radioligand therapy to cancer patients,...

RACA : 10.27 (+2.19%)
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility Business Wire - Tue Jun 1, 2021

POINT Biopharma Inc. (POINT), a radiopharmaceutical company dedicated to bringing the many benefits of precision radioligand therapy to cancer patients, announced today that the U.S. Nuclear Regulatory...

RACA : 10.27 (+2.19%)
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility Business Wire - Wed Apr 28, 2021

POINT Biopharma Inc. (POINT), a radiopharmaceutical company dedicated to bringing the many benefits of precision radioligand therapy to cancer patients, announced today that the U.S. Nuclear Regulatory...

RACB : 10.11 (+0.45%)
RACA : 10.27 (+2.19%)
Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I Globe NewsWire - Mon Mar 15, 2021

POINT Biopharma has entered into a definitive merger agreement with Research Alliance Corp. I (Nasdaq: RACA). Upon closing, the combined company is expected to be listed on Nasdaq under the ticker symbol...

RACA : 10.27 (+2.19%)
Cerevance Appoints David Lubner to Board of Directors Globe NewsWire - Tue Dec 8, 2020

Life sciences industry veteran brings more than 25 years of financial and operational experience

DYN : 26.24 (+0.61%)
RACA : 10.27 (+2.19%)
NITE : 25.41 (-0.04%)

Barchart Exclusives

Will This EV Stock Burn Short Sellers Like Tesla Did With Its Q1 Earnings Report? Barchart - Mon May 6, 8:37AM CDT
Rivian will release its Q1 earnings after the bell this Tuesday, May 7. The setup for the EV startup looks good heading into the release, which could set the stage for a post-earnings rebound like we saw with Tesla. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot